In the published article, 1 affiliation 9 was corrected to:
IRCCS Azienda Ospedaliero‐Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
The author apologizes for this error. The original article in the online version has been updated.
REFERENCE
- 1. Larocca A, Leleu X, Touzeau C, Bladé J, Paner A, Mateos M‐V, et al. Patient‐reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study. Br J Haematol. 2022;196:639–48. 10.1111/bjh.17887 [DOI] [PMC free article] [PubMed] [Google Scholar]